4-Nitro heptanedial

4-Nitro heptanedial

Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.


Product Name:                  4-Nitro heptanedial

Synonyms:                         N/A

CAS Number:                     147189-43-3

Molecular Weight:            173.1682

Molecular Formula:          C7H11NO4

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=CCCC([N+]([O-])=O)CCC=O

  • $600.00
  • Ex Tax: $600.00

Available Options